The consumer-citizen duality: Ten reasons why citizens prefer safety and drivers desire speed.

Accid Anal Prev

Delft University of Technology, Faculty of Technology, Policy and Management, Transport and Logistics Group, Jaffalaan 5, 2628 BX, Delft, The Netherlands. Electronic address:

Published: December 2018

Cost-benefit analyses for transportation projects usually value impacts on safety and travel time through experiments in which consumers of mobility ('drivers') choose between routes which differ in safety and travel time. This approach has been criticized for failing to consider that private choices may not fully reflect citizens' preferences over public goods and means, a concept known as the consumer-citizen duality. Recent empirical evidence has established that individuals do indeed assign comparatively more value to safety in their role as citizens than in their role as drivers. Our study aims to provide explanations for this finding by presenting four stated choice experiments in which respondents were asked to make choices, both as citizens and as drivers, between routes that differed in travel time and safety. Subsequently, respondents were asked to provide reasons for their choices. We identify five cognitive and five normative explanations. The cognitive explanations suggest that individuals make diverging choices because their perceptions of accident risk differ between the two roles. Drivers will assign a relatively low value to mitigating accident risk because they believe that: (1) such risks are trivial on an individual level; (2) their personal risk is lower than the average risk; (3) their personal risk is controllable; (4) they would not be able to distinguish relative safety levels in real life; and (5) their choices for others are more risk-averse than choices for themselves and, unlike citizens, they are not explicitly evaluating risky choices for others. The normative explanations involve that individuals believe that the government should assign more value to safety compared to individual drivers because: (6) as citizen they are more prone to base their choices on social norms which prescribe risk-averse behaviour in this context; (7) governments have a duty of care concerning the safety of the transportation network; (8) drivers have a relatively high degree of responsibility to reduce their own travel times; (9) governments should account for drivers' tendencies to choose faster routes by building safer ones; and (10) governments should ensure the safety of the road network because this allows drivers to choose the fastest route without being concerned about the impact of their route choice on accident risk.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.aap.2018.08.027DOI Listing

Publication Analysis

Top Keywords

travel time
12
accident risk
12
safety
9
consumer-citizen duality
8
safety travel
8
choices
8
respondents asked
8
choices citizens
8
normative explanations
8
personal risk
8

Similar Publications

In chronic lymphocytic leukemia, the reliability of next-generation sequencing (NGS) to detect variants ≤10% allelic frequency (low-VAF) is debated. We tested the ability to detect 23 such variants in 41 different laboratories using their NGS method of choice. The sensitivity was 85.

View Article and Find Full Text PDF

Introduction: SPLASH (NCT04647526) is a multicenter phase III trial evaluating the efficacy and safety of [Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer (mCRPC). This study leveraged a lead-in phase to assess tissue dosimetry and evaluate preliminary safety and efficacy, prior to expansion into a randomized phase. Here we report those results.

View Article and Find Full Text PDF

Background: Tecovirimat, an antiviral treatment for smallpox, was approved as a treatment for mpox by the European Medicines Agency in January 2022. Approval was granted under "exceptional circumstances" based on effectiveness found in pre-clinical challenge studies in animals and safety studies in humans showing minimal side effects. As clinical efficacy studies are still ongoing, there is currently limited information with regard to the acceptability of tecovirimat to treat mpox.

View Article and Find Full Text PDF

Background: Driving under the influence of alcohol and other drugs contributes significantly to road traffic crashes worldwide. This study explored trends of alcohol, methylamphetamine (MA), 3,4-methylenedioxy-N-methylamphetamine (MDMA) and Δ9-tetrahydrocannabinol (THC), in road crashes from 2010 to 2019 in Victoria, Australia.

Methods: We conducted a cross-sectional analysis using data from the Victorian Institute of Forensic Medicine and Victoria Police, examining proscribed drug detections in road crashes.

View Article and Find Full Text PDF

Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST).

Thromb Haemost

January 2025

Centre de Ressources et Compétences des Maladies Hémorragiques Constitutionnelles, CHU Clermont-Ferrand, Estaing Hospital, Clermont-Ferrand, France.

Background:  The Hemophilia Functional Ability Scoring Tool (Hemo-FAST), consisting of a patient-reported outcome (PRO) part and a clinician-reported outcome (ClinRO) part, was developed as a rapid and effective tool to assess functional mobility in clinical practice. This study (NCT04731701) aimed to validate the psychometric properties of Hemo-FAST for assessment of joint health in people with haemophilia (PwH).

Methods:  PwH A or B aged ≥18 years completed questionnaires including the PRO part of Hemo-FAST and the short-form 36 health survey (SF-36) during one study visit.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!